.-Endothelial nitric oxide synthase (NOS) and neuronal NOS protein increased in proximal tubules of acidotic diabetic rats 3-5 wk after streptozotocin injection. NOS activity (citrulline production) was similar in nondiabetic and diabetic tubules incubated with low glucose (5 mM glucose ϩ 20 mM mannitol); but after 30 min with high glucose (25 mM), Ca-sensitive citrulline production had increased 23% in diabetic tubules. Glucose concentration did not influence citrulline production in nondiabetic tubules. High glucose increased carboxy-2-phenyl-4,4,5,5,-tetramethylimidazoline 1-oxyl-3-oxide (cpt10)-scavenged NO sevenfold in a suspension of diabetic tubules but did not alter NO in nondiabetic tubules. Diabetes increased ouabain-sensitive 86 Rb uptake (141 Ϯ 9 vs. 122 Ϯ 6 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 ) and oligomycin-sensitive O 2 consumption (Q O2; 16.0 Ϯ 1.7 vs. 11.3 Ϯ 0.7 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 ). Ethylisopropyl amiloride-inhibitable Q O2 (6.5 Ϯ 0.6 vs. 2.4 Ϯ 0.3 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 ) accounted for increased oligomycin-sensitive Q O2 in diabetic tubules. N Gmonomethyl-L-arginine methyl ester (L-NAME) inhibited most of the increase in 86 Rb uptake and Q O2 in diabetic tubules. L-NAME had little effect on nondiabetic tubules. Inhibition of Q O2 by ethylisopropyl amiloride and L-NAME was only 5-8% additive. Uncontrolled diabetes for 3-5 wk increases NOS protein in proximal tubules and makes NOS activity sensitive to glucose concentration. Under these conditions, NO stimulates Na-K-ATPase and Q O2 in proximal tubules. oxygen consumption; nitric oxide synthase; sodium-hydrogen exchange; kidney; streptozotocin; oligomycin; ouabain; rubidium uptake; ketoacidosis; N G -monomethyl-L-arginine methyl ester; ethylisopropyl amiloride CONTROVERSY SURROUNDS THE effect of diabetes on renal nitric oxide (NO) production. Is expression of NO synthase (NOS) increased (22, 34, 37) or decreased (19, 20, 31)? Is NO production increased, decreased, or unchanged? Does NO stimulate or inhibit Na transport by proximal tubules? Some of this ambiguity can be attributed to changes in NO production as diabetes progresses. In the first 1-2 wk of streptozotocin-induced diabetes, NOS mRNA and protein expression are unchanged or decreased (19, 20, 31) . After 2 wk, NOS expression increases in the renal cortex and outer medulla (32) endothelium, mesangium, and macula densa (22, 34, 37) . Endothelial NOS (eNOS) protein also increases in proximal convoluted and straight segments, and neuronal NOS (nNOS) protein increases in the straight proximal segment (32).
are unchanged or decreased (19, 20, 31) . After 2 wk, NOS expression increases in the renal cortex and outer medulla (32) endothelium, mesangium, and macula densa (22, 34, 37) . Endothelial NOS (eNOS) protein also increases in proximal convoluted and straight segments, and neuronal NOS (nNOS) protein increases in the straight proximal segment (32) .
NO production depends not only on NOS protein expression but also on cofactors [calcium, reduced NADP (NADPH), tetrahydrobiopterin, and FAD] and on posttranscriptional modification by kinases (10, 17, 19) . Changes in one or more cofactors or phosphorylation by kinases may account for increased NO production without increased NOS protein in rat renal cortex 14 days after streptozotocin injection (19) .
There is also controversy about the effect of NO on proximal tubule function. Basal NO production stimulates Na/H exchange in proximal tubules of nondiabetic rats (4, 14, 38, 39) , whereas higher NO concentrations from exogenous sources inhibit Na/H exchange and Na reabsorption [reviewed by Liang and Knox (25) ]. Hypoxia enhances inhibition by NO (21) . These observations suggest that NO might either enhance or diminish adaptation of Na/H exchange as diabetic ketoacidosis progresses (3, 15) . In the experiments described below, we examined the connections between NO and Na/H exchange in proximal tubules of mildly acidotic diabetic rats 3-5 wk after streptozotocin injection. We measured NOS protein expression, NO production, and the effects of inhibiting NO production on 86 Rb uptake and oxygen consumption (Q O 2 ) in isolated tubule fragments.
METHODS
Male Wistar rats (250 g; Charles River) were injected with streptozotocin (55 mg/kg body wt ip). They were considered to be diabetic if their tail blood glucose, collected in the morning, exceeded 18 mM. Three to five weeks after the streptozotocin injection, the rats were anesthetized with pentobarbital sodium (100 mg/kg body wt ip), venous blood was collected, and kidneys were removed. Plasma was analyzed for glucose, Na, K, Cl, HCO 3, and creatinine with a COBAS Integra. NO 2 ϩ NO3 in urine was measured with a modified Griess reaction (30) . Some rats were housed in metabolic cages, and urine was collected daily for 3-5 days before removal of their kidneys.
Tubules were prepared from outer cortical slices as previously described (5) . The kidneys were cleared of blood by infusing 60 ml of isotonic saline through the aorta. Slices were removed from the outer cortex with a Stadie-Riggs microtome, placed in ice-cold saline, and minced finely with a razor blade. The minceate was incubated at 37°C for 30 min in 6 ml of Krebs-Henseleit buffer containing 7.2 mg of collagenase (Sigma) and 30 mg of bovine serum albumin. The reaction was stopped with ice-cold buffer solution. The tissue was passed through a tea strainer, washed four times with buffer, and suspended in 30 ml of 45% Percoll in KrebsHenseleit buffer. Tubules were separated from glomeruli by centrifugation in a 60Ti rotor at 20,000 rpm for 20 min. Microscopic examination showed that the bottom layer, containing 80-90% proximal tubule fragments with virtually no glomeruli, was washed four times with buffer and passed once through a 100-m sieve. Tubules were kept on ice in a modified Krebs-Henseleit solution, which contained (in mM) 136 Na, 5 K, 111 Cl, 25 HCO 3, 0.5 Mg, 1 Ca, 5 or 25 glucose, 2 lactate, 0.2 pyruvate, 2 glutamine, 1 arginine, 1 alanine, and 1 heptanoic acid, as well as 10 g/l bovine serum albumin. The pH was 7.4 at 37°C when equilibrated with 95% air-5% CO2.
Before measurement of Q O2, tubules were incubated at 37°C with 95% air-5% CO2 for 30 min in the modified KrebsHenseleit solution with either high glucose (25 mM) or low glucose (5 mM glucoseϩ20 mM mannitol). Inhibitors, ethylisopropyl amiloride (EIPA; 10 M), phloridzin (100 M), and oligomycin (20 M), were added to the incubation solution 2-5 min before measurement of Q O2. N G -monomethyl-L-arginine methyl ester (L-NAME) and N G -monomethyl-D-arginine methyl ester (10 mM) were added 30 min before measurement of Q O2. Sigma (St. Louis, MO) provided chemicals and inhibitors unless otherwise noted. Measurements were started by injecting tubules (0.8-1.6 mg of protein) into the 0.6-ml analytic chamber (Diamond General Development, Ann Arbor, MI) containing buffer solution with or without inhibitors preequilibrated with 95% air-5% CO2 at 37°C. PO2 was recorded polarographically with a YSI model 5300 biological oxygen monitor. Comparisons with and without inhibitors were done in duplicate when responses with high and low glucose were obtained with the same tubule preparation. When one glucose concentration was used, the result for each tubule preparation was the average of triplicate or quadruplicate measurements. Tubules were washed from the chamber with saline for protein measurement.
Ouabain-sensitive 86 Rb uptake by proximal tubule fragments was used to measure Na-K-ATPase activity (5) .
86 Rb (PerkinElmer, Boston, MA) was added to produce an activity of ϳ1 Ci/ml with ϳ2 mg of tubule protein. Uptake was measured with and without 2.5 mM ouabain. Uptake was terminated after 1 min by layering the tubule suspension onto 0.5 ml of a 2:1 mixture of dibutyl-dioctylphthalate in a 1.5-ml centrifuge tube and centrifuging for 10 s in an Eppendorf 5414 centrifuge. The medium above the oil layer was removed, and the tubule was rinsed five times with distilled water without disturbing of the oil. The pellet of tubules was dissolved in 1 ml of 0.1 N NaOH, and 200 l of the solution were added to 10 NOS activity was measured in three ways: citrulline production in tubule homogenates, citrulline production in intact tubule fragments, and NO concentration in the incubation medium. Before NOS activity was measured, the tubules were incubated in either high-or low-glucose solution at 37°C for 30 min. Tubules were briefly washed in ice-cold saline before they were homogenized according to the method of Chin et al. (11) . NOS activity in the homogenate was measured in 100 l of a solution containing (in mM) 50 KH 2PO4, 1 MgCl2, 1 CaCl2, 1 NADPH, and 0.022 L-arginine, as well as 3 mol/l of U-[
14 C]arginine HCl (Amersham). Duplicate samples were incubated for 1 h at 37°C with no inhibitors, with 4 mmol/EGTA, and with 4 mM EGTAϩ5 mM L-NAME. The reaction was stopped by adding 1.5 ml of a 1:1 suspension of Dowex 50W (Na form) in water. The solution was centrifuged, 5 ml water were added, and the solution was recentrifuged. Two hundred microliters of the supernatant were used for radioactive counting. In pilot experiments, we found that adding 50 mM valine, 100 mM biopterin, 100 mM FAD, and 1 g/ml calmodulin did not alter the results; therefore, these cofactors were omitted from the assay mixture. NOS activity in intact tubule fragments was measured by incubating tubules with [ 3 H]arginine (59 Ci/mmol; Amersham) in Krebs-Henseleit buffer gassed with 95% air-5%CO2 at 37°C for 1 h. The reaction was stopped with 1 ml of ice-cold 4 mM EDTA, and tubules were homogenized for 30 s with a Polytron. After centrifugation, citrulline and arginine were separated with Dowex as described above.
NO produced by proximal tubule fragments was measured with a Clark-type electrode (Diamond General) in 2.5 ml of HEPES-buffered Krebs-Henseleit containing 1,000 U/ml superoxide dismutase, at 36.5°C in a shaking water bath (42, 43) . NO for daily calibration was generated from NaNO 2 (0.05 mM) in KI, H2SO4, and K2SO4. The electrode reacted linearly to the NO standard and to increasing concentrations of S-nitroso-N-acetylpenicillamine (SNAP). NO concentration in the bathing medium was calculated from the decrease produced by adding 50 g carboxy-2-phenyl-4,4,5,5,-tetramethylimidazoline 1-oxyl-3-oxide (cpt10; Research Biochemicals International, Natick, MA). NO consumption by tubules was assessed by adding SNAP (1 M) to the tubule suspension. The area under the curve of SNAP concentration (concentration ϫ time), measured by cutting out and weighing the chart paper, was similar for diabetic and nondiabetic tubules.
For Western blotting, tubule fragments were incubated at 37°C with high or low glucose for 30 min before homogenization in boiling 1% SDS, 10 mM Tris, pH 7.4, and 1 mM Na orthovanadate. Protein samples (200 g) were run on 7.5% Tris ⅐ HCl Ready Gels (Bio-Rad) in a Bio-Rad minigel apparatus at 200 constant V for ϳ30 min. Proteins were transferred to Immobilon-P membranes (Millipore, Bedford, MA) at 100 V for 3 h at 4°C. The membranes were blocked with 5% nonfat dry milk, 10 mM Tris, pH 7.5, 100 mM NaCl, and 0.1% Tween 20 for 1 h at room temperature. They were then incubated overnight with 1:2,500 dilution of mouse monoclonal antibodies against nNOS, inducible NOS (iNOS), and eNOS (Transduction Laboratories) and visualized with 1:1,000 horseradish peroxidase-labeled goat anti-mouse with enhanced chemiluminescence immunodetection (Amersham). 1). Plasma unmeasured anion gap (Na-Cl-HCO 3 ), creatinine clearance, and NO 2 ϩ NO 3 excretion (NOx) were higher and plasma bicarbonate was lower (26.7 Ϯ 0.8 vs. 29.3 Ϯ 0.6 mM, P ϭ 0.03) in the diabetic rats. Part of the increase in creatinine clearance and NOx excretion can be attributed to increased renal mass. NOx excretion correlated with creatinine clearance in both groups of rats (nondiabetic, r 2 ϭ 0.28; diabetic, r 2 ϭ 0.33).
Western blot analysis showed 3.5-fold more eNOS (P Ͻ 0.001) and 1.5-fold more nNOS protein (P ϭ 0.017) in diabetic tubules but no iNOS in tubules from nondiabetic or diabetic rats (Fig. 1) . The tubules used to prepare Fig. 1 were incubated with high glucose for 30 min before being homogenized. In other experiments, we incubated duplicate aliquots from diabetic tubule preparations with high or low glucose. Glucose concentration did not influence NOS protein expression (n ϭ 4 pairs of duplicates, data not shown).
After 30 min with low glucose, NOS activity was similar in proximal tubule homogenates from diabetic and nondiabetic rats. Roughly two-thirds of the citrulline production was calcium sensitive (Fig. 2A ). Thirty minutes with high glucose increased calcium-sensitive citrulline production by 23% in diabetic tubules, but there was no change in nondiabetic tubules. High glucose did not alter calcium-insensitive citrulline production (Fig. 2B) . High glucose also stimulated NO production when intact diabetic tubule fragments were incubated without NADPH or other cofactors (Table 2) . High glucose did not alter citrulline production by nondiabetic tubule fragments.
We used NO released from SNAP to examine the effects of different incubation media and tubules on NO consumption. The pattern of NO release from SNAP was identical in low glucose (5 mM glucose ϩ 20 mM mannitol) and high glucose (25 mM). Diabetic and nondiabetic tubules decreased the amount of NO detected from SNAP to the same extent. With high glucose, the areas under the curves for NO released from SNAP were 51 Ϯ 10 (n ϭ 8) and 55 Ϯ 10 (n ϭ 8) arbitrary units for nondiabetic and diabetic tubules, respectively. Ambient NO concentration in the tubule suspension was estimated from the decrease in the signal produced by the NO scavenger cpt10 (Table 3) . High glucose increased cpt10-scavenged NO with diabetic tubules (P Ͻ 0.001) but numerically decreased NO concentration with nondiabetic tubules.
Ouabain inhibited 75 Ϯ 4% of 86 Rb uptake in nondiabetic tubules and 79 Ϯ 3% in diabetic tubules (P ϭ 0.09). Diabetes increased ouabain-sensitive 86 Rb uptake by 16% (Table 4) . Incubation with L-NAME (10 mM) for 20 min reduced 86 Rb uptake in diabetic tubules by 16% but had little effect on control tubules. Consequently, the difference in 86 Rb uptake between diabetic and nondiabetic tubules was largely obliterated by L-NAME.
Tubules from diabetic rats consumed 36% more oxygen than tubules from nondiabetic rats when both were incubated in high glucose (P Ͻ 0.001). Glucose concentration had no effect on Q O 2 with nondiabetic tubules (24.7 Ϯ 1.1 vs. 24.9 Ϯ 0.9 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 ), but high glucose modestly increased Q O 2 by diabetic tubules (32.8 Ϯ 1.0 vs. 30.2 Ϯ 1.1 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 ). The interaction between glucose and diabetes was significant (2-way repeated measures ANOVA, P ϭ 0.02). Diabetes substantially increased oligomycin-sensitive Q O 2 (16.0 Ϯ 1.7 vs. 11.3 Ϯ 0.7 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 , P ϭ Values are means Ϯ SE. n, No. of rats; NOx, urine excretion of NO2 ϩ NO3. Diabetic rats were injected with streptozotocin 3-5 wk before 18-h urine collection. Unmeasured anion gap was calculated from venous plasma Na Ϫ (Cl ϩ HCO3). (Fig. 3) . Increased oligomycin-sensitive Q O 2 can be entirely attributed to the increase in EIPA-inhibited Q O 2 (Figs. 3 and 4) . The phloridzin-sensitive component of Q O 2 was not increased in diabetic tubules (2.2 Ϯ 0.6 vs. 1.8 Ϯ 0.7 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 ) (Fig. 3 ). L-NAME-inhibited Q O 2 was more than doubled in diabetic tubules compared with nondiabetic tubules [4.5 Ϯ 0.7 (n ϭ 10) vs. 2.0 Ϯ 0.5 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 (n ϭ 9), P ϭ 0.01]. In a smaller number of experiments, inhibition by EIPA and L-NAME was compared by using paired analyses with the same tubule preparations (Fig. 5) . According to repeated-measures ANOVA, there was an interaction between EIPA and L-NAME; however, the combined effect was only 5-8% of the expected increase if the inhibitors were additive when used together (Fig. 5) . N G -monomethyl-D-arginine methyl ester did not alter Q O 2 appreciably (ϩ0.7 and Ϫ0.9 Ϯ 0.6 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 in nondiabetic and diabetic tubules, respectively).
DISCUSSION
NOS RNA and protein are unchanged or decrease for the first 1-2 wk after streptozotocin injection (19, 20, 31) . Thereafter, NOS expression increases in the renal cortex and outer medulla (22, 32, 34, 37) , and immunohistochemical staining of eNOS and nNOS increases in proximal tubules (32) . NOS activity, measured as citrulline production, rises after 2 wk, even before there is a detectable change in NOS protein (19) . Three to five weeks of uncontrolled diabetes not only increases NOS proteins in proximal tubules (Fig. 1 ) but also increases NOS activity and makes it sensitive to glucose concentration (Fig. 2, Tables 1-3 ). NOS activity in tubules from nondiabetic rats is not sensitive to glucose concentration.
High glucose also increases the steady-state concentration of NO that can be scavenged by cpt10 (Table 3) . This observation is consistent with the effect of glucose on citrulline production. When measuring NO, we (4) 58 Ϯ 22 (6) 14 Ϯ 3 (7) 107 Ϯ 12*
Values are means Ϯ SE with no. of experiments in parentheses. Tubule protein was not significantly different (1-way ANOVA). Nitric oxide (nmol/l) was analyzed by 2-way ANOVA. Glucose effect, P Ͻ 0.001. Interaction of glucose and diabetes, P Ͻ 0.001. Diabetic high glucose is different from diabetic low glucose and nondiabetic high and low glucose, * P Ͼ 0.01. Ouabain-sensitive (5) 122 Ϯ 6 141 Ϯ 9 L-NAME (3) 118 Ϯ 9 123 Ϯ 3*
Values are means Ϯ SE with no. of paired experiments, each done in duplicate, in parentheses. Proximal tubule fragments were incubated in 25 mM glucose for 20 min with or without 2.5 mM ouabain or 10 mM N G -monomethyl L-arginine methyl ester (L-NAME) before addition of 86 Rb. According to repeated-measures ANOVA, the effect of L-NAME and the interaction between L-NAME and diabetes are both significant; * P Ͻ 0.001 with vs. without L-NAME (Student's paired t-test).
added superoxide dismutase (SOD) to remove reactive oxygen species (19, 35) . SOD was not added to the incubation mixture for measurement of Q O 2 and 86 Rb uptake; therefore, the NO measurements may not reflect NO concentrations during those measurements. In diabetic tubules, increased reactive oxygen species production is partially counterbalanced by increased SOD expression (19) . The net effect on NO concentration in vivo is unknown. Binding of NO to glucose (8) did not produce differences between low-and highglucose measurements, because the low-glucose solution contained 20 mM mannitol, which also binds NO. In summary, both cpt10-scavenged NO and citrulline production show increased NO production by diabetic tubules but only in the presence of high glucose concentration.
Adaptation to prolonged hyperglycemia alters signal transduction (12) and metabolism in ways that could affect NOS activity. For example, brief exposure to high glucose increases protein kinase C (PKC) activity in LLC-PK 1 and opossum kidney (OK/E) cells after they have been grown with high glucose for several days. High glucose does not increase PKC activity in cells that have been grown with low glucose (12) . PKC, activated by high glucose, could stimulate NO production by phosphorylating the NOS enzyme or a cofactor (16, 17, 19) . Metabolic adaptation to constant hyperglycemia could also sensitize NOS activity to glucose concentration by altering the level of essential metabolic cofactors. In our experiments, the assay mixture did not include calmodulin, FAD, and reduced tetrahydrobiopterin; therefore, NOS activity was determined by the availability of these cofactors in the tubule fragments or homogenate. Cellular levels of reduced G -monomethyl-L-arginine methyl ester (L-NAME), or EIPA and L-NAME together. Tubules were incubated with high glucose. Repeated measures were made with 3 nondiabetic and 6 diabetic tubule preparations. Repeated-measures ANOVA showed significant inhibitory effects of L-NAME and EIPA and an interaction between L-NAME and EIPA. Values are means Ϯ SE. Inhibition was significantly greater in tubules from diabetic rats (P values for a comparison of diabetic with nondiabetic tubules are shown above error bars, Student's unpaired t-test).
tetrahydrobiopterin may be the most vulnerable to modulation by prolonged hyperglycemia. NO production requires the formation of a complex between reduced tetrahydrobiopterin and NOS (40) . Reduction of tetrahydrobiopterin depends on NADPH concentration, which may be altered by increased glucose flux through aldose reductase and pentose phosphate pathways in diabetic tubules. Preincubation of diabetic tubules with high glucose could facilitate the production of the active NOS-reduced tetrahydrobiopterin complex.
The remainder of this discussion deals with the effects of NO production on proximal tubule function. Endogenous NO production has been linked to stimulation of Na reabsorption through Na/H exchange in proximal tubules (4, 14, 38, 39) . However, a number of other studies indicate that NO reduces reabsorption by inhibiting Na/H exchange, Na-K-ATPase, or mitochondrial oxidative phosphorylation (1, 25, 26, 29) . Inhibition is inversely proportional to PO 2 (21) . When PO 2 falls below 40 mmHg, physiologically relevant NO concentrations [ϳ100 nM (24) ] begin to inhibit Q O 2 by proximal tubules, and inhibition increases as PO 2 approaches zero. In our experiments, the PO 2 in tubule suspensions equilibrated with 95% air was ϳ140 mmHg. The highest concentration of cpt10-scavenged NO in diabetic hyperglycemic tubule suspensions was similar to concentrations found in proximal tubule fluid of nondiabetic rats in vivo (24) . NO in such a low concentration is unlikely to inhibit Q O 2 and Na transport under the conditions of high PO 2 that pertained to our experiments. However, a similar low-NO concentration might be inhibitory under hypoxic conditions, such as those found in slices of kidney cortex (1, 7) .
To explore the consequences of inhibiting NO production on proximal tubule function, we measured Na-K-ATPase ( 86 Rb uptake) and Q O 2 . Diabetes increased 86 Rb uptake (Table 4 ) and Q O 2 (Fig. 3) . Both the oligomycin-inhibited and oligomycin-insensitive components of Q O 2 increased (Fig. 4) (6) . Oligomycin-inhibited Q O 2 reflects O 2 used for oxidative phosphorylation to produce ATP, most of which is consumed by Na-KATPase. The efficiency of O 2 use for K transport by Na-K-ATPase can be estimated from the ratio of 86 Rb uptake to oligomycin-sensitive Q O 2 . [Actually, the ratio underestimates the efficiency of Q O 2 to provide ATP for Na-K-ATPase, because oligomycin inhibits the production of ATP used for all ATPases, including, for example, H ϩ -ATPase (9) .] Theory predicts that if each O 2 generates 6 ATP molecules and each ATP transports 2 K (or 86 Rb) equivalents, then the ratio will be 12. For nondiabetic tubules with high glucose, the ratio was 122:11.3 or 10.8, and for diabetic tubules it was 141:16 or 8.8. Diabetes is associated with increased serumfree fatty acids and increased fatty acid metabolism by proximal tubules (18) . Fatty acid oxidation produces only four ATP molecules for each O 2 consumed; therefore, a lower ratio is to be expected in the diabetic tubules.
In vivo hyperglycemia increases proximal tubule reabsorption by delivering more glucose in glomerular filtrate for reabsorption along the proximal tubule (36) . However, the effects of diabetes on Q O 2 in tubule fragments were not due to increased Na-glucose cotransport. Inhibiting Na-glucose cotransport with phloridzin reduced Q O 2 to a similar extent in diabetic and nondiabetic tubules incubated with high glucose (Fig. 3) . Five millimolar glucose exceeds the 1.6 mM K m for glucose transport with Na in proximal tubule S1 and S2 segments (33) . Therefore, raising glucose from 5 to 25 mM had no effect on phloridzin-inhibited Q O 2 .
EIPA-inhibited Q O 2 , probably reflecting ATP consumption secondary to Na entry through Na/H exchange, accounted for 19% of the oligomycin-inhibited Q O 2 in nondiabetic tubules and 40% in diabetic tubules (Fig. 4) . When EIPA-inhibited Q O 2 is subtracted from the oligomycin-sensitive Q O 2 , the remainder is almost identical in diabetic and nondiabetic tubules (9.5 and 9.3 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 , respectively). Thus it appears that Na/H exchange (28) was responsible for increased ATP consumption by diabetic tubule fragments. Diabetes might increase the inhibitory effect of EIPA on Na-K-ATPase, but this is less likely than an effect on Na/H exchange, which we know is increased with untreated streptozotocin diabetes (15) .
Inhibiting NO production decreased Na-K-ATPase activity [ 86 Rb uptake (Table 4 ) and Q O 2 ( Fig. 5) ] in diabetic tubules but had little effect in nondiabetic tubules. The small response in nondiabetic tubules is consistent with some stimulation of Na transport through Na/H exchange as observed in nondiabetic tubules by others (13) . If NO acts by stimulating Na/H exchange (39, 4, 25) , then inhibition of NO production should have no additional effect on Q O 2 when Na/H exchange is blocked by EIPA. This supposition is supported by the finding that L-NAME inhibition and EIPA inhibition are only 5-8% additive (Fig. 5) . Increased Na/H exchange is a well-known consequence of metabolic acidosis (3, 41) . The recent observation that nNOS knockout mice develop metabolic acidosis (39) suggests that NO production could play a role in longterm adaptation to diabetic metabolic acidosis. Acidosis increases NOS expression in brain cells (27) , but the effect of chronic acidosis on renal NOS expression has not been reported to our knowledge. Increased osmolality associated with hyperglycemia might also contribute to increased expression of the Na/H exchanger (2) . Further experiments are required to establish the relative roles of acidosis and hyperglycemia in long-term regulation of NOS expression, NO production, and their relationship to Na/H exchange.
Diabetes also increased Q O 2 for purposes other than ATP production (oligomycin-insensitive Q O 2 , 15.9 Ϯ 0.5 vs. 12.2 Ϯ 0.6 nmol ⅐ min Ϫ1 ⅐ mg
Ϫ1
, P Ͻ 0.001, unpaired Student's t-test). Similar results were obtained by Korner et al. (23) , who found that streptozotocin diabetes increased Q O 2 by 32% in rat proximal tubule cells, with 45% of the increase being insensitive to ouabain. The increase of oligomycin-insensitive Q O 2 in diabetic tubules may be related to increased expression of uncoupling protein 2 and increased levels of free fatty acid, which uncouple Q O 2 from ATP production (6).
In summary, streptozotocin-induced diabetes increases eNOS and nNOS protein expression, and high glucose concentrations stimulate NO production in diabetic proximal tubules. Increased NO production under hyperglycemic conditions stimulates Na/H exchange. The role of NO in the adaptation of Na/H exchange to the diabetic state deserves further investigation.
